Applied psychometrics in clinical psychiatry: The pharmacopsychometric triangle

Acta Psychiatrica Scandinavica

Volumn 120, Issue 5, 2009, Pages 400-409

  Bech, P ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Clinimetrics; Item response theory models; Pharmacopsychometric triangle; Rating scales

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; CITALOPRAM; DIAZEPAM; ESCITALOPRAM; FLUOXETINE; HALOPERIDOL; IMIPRAMINE; MIRTAZAPINE; OLANZAPINE; PAROXETINE; PLACEBO; PREGABALIN; RISPERIDONE; VENLAFAXINE; ZUCLOPENTHIXOL;

ANXIETY DISORDER; CLINICAL ASSESSMENT; CLINICAL TRIAL; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; GENERALIZED ANXIETY DISORDER; HUMAN; MAJOR DEPRESSION; MANIA; NAUSEA; OPTIMAL DRUG DOSE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSYCHIATRY; PSYCHOLOGICAL RATING SCALE; PSYCHOMETRY; PSYCHOPHARMACOLOGY; QUALITY OF LIFE; REVIEW; SIDE EFFECT; SWEATING;

HUMANS; MENTAL DISORDERS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; PSYCHOPHARMACOLOGY; PSYCHOTROPIC DRUGS;

EID: 70349696507     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/j.1600-0447.2009.01445.x     Document Type: Review

References (71)

1. Bech P, Kastrup M, Rafaelsen OJ. Mini-compendium of rating scales for anxiety, depression, mania, and schizophrenia. Acta Psychiatr Scand 1986 73 (Suppl. 326 1 36.
2. Lingjærde O, Ahlfors UG, Bech P, Denscher SJ, Elgen K. The UKU Side Effect Rating Scale. Acta Psychiatr Scand 1987 76 (suppl. 334 7 100.
3. Bech P, Ahlfors UG, Dencker SJ, Elgen K, Lingjærde O. UKU's bivirkningsskala. Skala til registrering af uønskede virkninger af psykofarmaka. (UKU's side effect scale for measuring unwanted effects of psychopharmacological drugs). Nord J Psychiatr 1986 40 : 147 157.
4. Bech P, Olsen RL, Kjoller M, Rasmussen NK. Measuring well-being rather than absence of distress symptoms: a comparison of the SF-36 mental health subscale with the WHO-FIVE Well-Being Scale. Int J Meth Psychiatr Res 2003 12 : 85 91.
5. Sisask M, Värnik A, Kolves K, Konstabel K, Wasserman D. Subjective psychological well-being (WHO-5) in assessment of the severity of suicide attempt. Nord J Psychiatr 2008 62 : 431 435.
6. Bech P. Quality of life instruments in depression. Eur Psychiatry 1997 12 : 194 198.
7. Bech P. 50 years with the Hamilton scales for anxiety and depression. Psychother Psychosom 2009 78 : 135 142.
8. Martin-löft P. The notion of redundancy and its use as a qualitative measure of the discrepancy between a statistical hypothesis and a set of observational data. Scand J Statist 1974 1 : 3 18.
9. Montgomery SA, Åsberg M. A new depression scale designed to be sensitive to change. Brit J Psychiat 1979 134 : 382 389.
10. Spearman C. The abilities of man. New York : Macmillan, 1927.
11. Mckeown B, Thomas D. Q methodology. London : Sage Publications, 1988.
12. Bech P, Allerup P, Gram LF et al. The Hamilton Depression Scale. Evaluation of objectivity using logistic models. Acta Psychiatr Scand 1981 63 : 290 299.
13. Bech P, Allerup P, Reisby N. Assessment of symptom change from improvement curves on the Hamilton Depression Scales in trials with antidepressants. Psychopharmacology 1984 84 : 276 281.
14. Rasch G. Probalistic models for some intelligence and attainment tests. Copenhagen : Danish Institute for Educational Research, 1960 (reprinted by University of Chicago Press, Chicago, 1980).
15. Bech P. Rating scales for psychopathology, health status and quality of life. Berlin : Springer, 1993.
16. Overall JE, Gorham DR. The Brief Psychiatric Rating Scale. Psychol Rep 1962 10 : 799 812.
17. Overall JE. The Brief Psychiatric Rating Scale in psychopharmacological research. In : Pichot P, ed. Psychological measurements in psychopharmacology. Basel : Karger, 1974 : 67 68.
18. Kay SR, Opler LA, Lindenmayer JP. Reliability and validity of the Positive and Negative Syndrome Scale for Schizophrenia. Psychiatr Res 1988 23 : 99 110.
19. Bech P, Larsen JK, Andersen J. The BPRS psychometric developments. Psychopharmacol Bull 1988 24 : 118 121.
20. Andersen J, Larsen JK, Schultz V. The Brief Psychiatric Rating Scale. Dimensions of schizophrenia, reliability and construct validity. Psychopathology 1989 22 : 168 176.
21. Hafkenscheid A. Psychometric evaluation of a standardized and expanded Brief Psychiatric Rating Scale. Acta Psychiatr Scand 1991 84 : 294 300.
22. Hafkenscheid A. Reliability of a standardized and expanded Brief Psychiatric Rating Scale. Acta Psychiatr Scand 1993 86 : 1 6.
23. Bech P. The Bech-Rafaelsen Mania Scale in clinical trials of therapies for bipolar disorder: 20-year review of its use as an outcome measure. CNS Drugs 2002 16 : 47 63.
24. Young RC, Biggs JT, Ziegler VE et al. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978 133 : 429 435.
25. Bech P, Gex-Fabry M, Aubry J-M, Favre S, Bertschy G. Olazapine plasma level in relationship to antimanic effect in the acute therapy of manic states. Nord J Psychiatry 2006 60 : 181 182.
26. Gjerris A, Bech P, Broen-Christensen C, Geisler A, Klysner R, Rafaelsen OJ. Haloperidol plasma levels in relation to antimanic effect. In : Usdin E, Dahl S, Gram LF, Lingjærde O, eds. Clinical pharmacology and psychiatry. London : MacMillan, 1980 : 227 232.
27. Mishory A, Yaroslavsky Y, Bersudsky Y, Belmaker RH. Phenytoin as an antimanic anticonvulsant: a controlled study. Am J Psychiatry 2000 157 : 463 465.
28. Licht RW, Bysted M, Christensen H. Fixed-dosed risperidone in mania: an open experimental trial. Int Clin Psychopharmacol 2001 16 : 103 110.
29. Overall JE. The dimensions of manifest depression. Psychiatr Res 1962 1 : 239 245.
30. Bech P. P Pichot - a tribute to the European pharmacopsychologist on his 90th birthday. Eur Psychiatr Rev 2008 1 : 76 80.
31. Feighner JP, Boyer WF, Meredith CH, Hendrickson GC. A placebo-controlled inpatient comparison of fluvoxamine maleate and impramine in major depression. Int Clin Psychopharmacol 1989 4 : 239 244.
32. Politis AM, Papadimitriou GN, Theleritis CG, Psarros C, Soldatos CR. Combination therapy with amisulpiride and antidepressants. Prog Neuropsychopharmacol Biol Psychiatry 2008 32 : 1227 1230.
33. Norton KRW, Sireling LI, Bhat AV, Rao B, Paykel ES. A double blind comparison of fluvoxamine, imipramine and placebo in depressed patients. J Affect Dis 1984 7 : 297 308.
34. Bech P, Gram LF, Dein E. Qualitative rating of depressive states. Acta Psychiatr Scand 1975 51 : 161 170.
35. Lunn V. Afsind (Insanity). Copenhagen : Gyldendal, 1987.
36. Lehman H. Psychopharmacotherapy. In : Healy D, ed. The psychopharmacologists I. London : Chapman & Hall, 1996 : 159 186.
37. Santen G, Gomeni R, Danhof M, Pasqua OD. Sensitivity of the individual items of the Hamilton Depression Scale to response and its consequence for the assessment of efficacy. Psychiatr Res 2008 42 : 100 1009.
38. Hedges LV, Olkin I. Statistical methods for meta-analysis. Orlando, FL : Academic Press, 1985.
39. Bech P, Cialdella P, Haugh M et al. A meta-analysis of randomised controlled trials of fluoxetine versus placebo and tricyclic antidepressants in the short-term treatment of major depression. Br J Psychiatry 2000 176 : 421 428.
40. Entsuah R, Shaffer M, Zhang J. A critical examination of the sensitivity of unidimensional subscales derived from the Hamilton Depression Rating Scale to antidepressant drug effects. J Psychiatr Res 2002 36 : 437 448.
41. Bech P, Tanghøj P, Andersen HF, Overø K. Citalopram dose-response revisited using an alternative psychometric approach to evaluate clinical effects of four fixed citalopram doses compared to placebo. Psychopharmacology 2002 163 : 20 25.
42. Bech P, Tanghøj P, Cialdella P, Friis Andersen H, Pedersen AG. Escitalopram dose-response revisited: an alternative psychometric approach to evaluate clinical effects of escitalopram compared to citalopram and placebo in patients with major depression. Int J Neuropsychopharmacol 2004 7 : 283 290.
43. Bech P. Meta-analysis of placebo-controlled trials with mirtazapine using the core items of the Hamilton Depression Scale as evidence of a pure antidepressive effect in the short-term treatment of major depression. Int J Neuropsychopharmacol 2001 4 : 337 345.
44. Pinder RM, Zivkov M. On demonstrating the correct dose for new antidepressants. In : Balant LP, Benitez J, Dahl SG, Gram LF, Pinder RM, Potter WZ, eds. Clinical pharmacology in psychiatry: finding the right dose of psychotropic drugs. Brussels : European Commission, 1998 : 31 42.
45. Schweizer E, Rickels K. Placebo response in generalized anxiety: its effect on the outcome of clinical trials. J Clin Psychiatry 1997 58 (Suppl. 11 30 38.
46. Rickels K, Downing R, Schweizer E, Hassman H. Antidepressants for the treatment of generalized anxiety disorder. A placebo-controlled comparison of imipramine, trezodone and diazepam. Arch Gen Psychiatr 1993 50 : 884 895.
47. Meoni P, Salinas E, Brault Y, Hachet D. Pattern of symptom improvement following treatment with venlafaxine XR in patients with generalized anxiety disorder. J Clin Psychiatry 2001 62 : 888 893.
48. Stahl SM, Ahmed S, Haudiquet V. Analysis of the rate of improvement of specific psychic and somatic symptoms of generalized anxiety disorder during long-term treatment with Venlafaxine ER. CNS Spectr 2007 12 : 703 711.
49. Bech P. Dose-response relationship of pregabalin in patients with generalized anxiety disorder. A pooled analysis of four placebo-controlled trials. Pharmacopsychiatry 2007 40 : 163 168.
50. Bech P. Quality of life in the psychiatric patient. London : Mosby-Wolfe, 1998.
51. Sartorius N. Cross-cultural comparisons of data about quality of life. In : Aaronson NK, Beckmann J, eds. The quality of life in cancer patients. New York : Raven Press, 1987 : 19 24.
52. Dupuy HJ. The Psychological General Well-Being (PGWB) Index. In : Wenger NK, Mattson ME, Furberg CD, Elinson J, eds. Assessment of quality of life in clinical trials of cardiovascular therapies. New York : Le Jacq Publishing, 1984 : 184 188.
53. Ware JE. The SF-36 health survey. In : Spilker B, ed. Quality of life and pharmacoeconomics in clinical trials, 2nd edn. Philadelphia, PA : Lippincott-Raven, 1996 : 337 345.
54. Bech P, Lunde M, Bech-Andersen G, Lindberg L, Martiny K. Psychiatric outcome studies (POS): does treatment help the patients? A Popperian approach to research in clinical psychiatry. Nord J Psychiatry 2007 61 (suppl. 46 4 80.
55. Bech P. Social functioning. Should it become an endpoint in trials of antidepressants? CNS Drugs 2005 19 : 313 324.
56. Feinstein AR. Clinimetrics. New Haven, CT : Yale University Press, 1987.
57. Magee B, Milligan M. On blindness. Oxford : Oxford University Press, 1995.
58. Brunswik E. Perception and the representative design of psychological experiments. Los Angeles, CA : University of California Press, 1956.
59. Bech P. Fifty years with the Hamilton scales for anxiety and depression. Psychother Psychosom 2009 78 : 202 211.
60. Fleck MPA, Poirter-Littre MF, Guilfi G-D. Factorial structure of the 17-item Hamilton Depression Rating Scale. Acta Psychiatr Scand 1995 92 : 168 176.
61. Uher R, Farmer A, Maier W. Measuring depression: comparison and integration of three scales in the GENDEP study. Psychol Med 2008 38 : 289 300.
62. Hamilton M. The role of rating scales in psychiatry. Psychol Med 1976 6 : 347 349.
63. Pichot P. Psychological measurements in psychopharmacology. Basel : Karger, 1974.
64. Paykel ES. The clinical interview for depression. In : Sartorius N, Ban TA, eds. Assessment of depression. Berlin : Springer, 1986 : 304 315.
65. Pichot P. A century of psychiatry. Paris : Editions Roger Dacosta, 1983.
66. Ban T. Prolegomenon to clinical prerequisite: psychopharmacology and the classification of mental disorders. Prog Neuropsychopharmacol Biol Psychiatry 1987 11 : 527 580.
67. Engle RL. Medical diagnosis: past, present and future II. Philosophical foundations and historical development of our concepts of health, disease and diagnosis. Arch Intern Med 1963 112 : 520 529.
68. Klerman GL. The contemporary American scene: diagnosis and classification of mental disorders, alcoholism and drug abuse. In : Sarorius N, Jablensky A, Regier DA, Burke JD, Hirshfelt RMA, eds. Sources and tradition of classification in psychiatry. Bern : Hogrefe & Huber, 1990 : 93 137.
69. Spitzer RL. A manual for diagnosis and statistics. In : Healy D, ed. The psychopharmacologist's III. London : Arnold, 2000 : 415 430.
70. Leon AC, Shear MK, Portea L, Klerman GL. Effect size as a measure of symptom-specific drug change in clinical trials. Psychopharmacol Bull 1993 29 : 163 167.
71. Power M. Development of a common instrument for quality of life. In : Nosikov A, Gudex C, eds. EUROHIS Developing common instruments for health surveys. Amsterdam : IOS Press, 2003 : 145 163.